Secondary Logo

Journal Logo

Institutional members access full text with Ovid®

Metformin for Prevention of Hypertensive Disorders of Pregnancy in Women With Gestational Diabetes or Obesity

Systematic Review and Meta-analysis of Randomized Trials

Kalafat, E.; Sukur, Y. E.; Abdi, A.; Thilaganathan, B.; Khalil, A.

Obstetrical & Gynecological Survey: May 2019 - Volume 74 - Issue 5 - p 263–265
doi: 10.1097/01.ogx.0000557706.35713.d0

(Abstracted from Ultrasound Obstet Gynecol 2018;52:706–714)

Preeclampsia is a leading cause of maternal mortality and morbidity that imposes a substantial burden on the health care system. Metformin has been reported to reduce the risk of preeclampsia.

Department of Obstetrics and Gynecology, Ankara University Faculty of Medicine (E.K., Y.E.S.); Department of Statistics, Middle East Technical University (E.K.), Ankara, Turkey; Fetal Medicine Unit, St George's University Hospitals NHS Foundation Trust, University of London (E.K., A.A., B.T., A.K.); and Vascular Biology Research Centre, Molecular and Clinical Sciences Research Institute, St George's University of London (B.T., A.K.), London, UK

Copyright © 2019 Wolters Kluwer Health, Inc. All rights reserved.